Increased Mortality Associated with Growth Hormone Treatment in Critically Ill Adults
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The administration of growth hormone can attenuate the catabolic response to injury, surgery, and sepsis. However, the effect of high doses of growth hormone on the length of stay in intensive care and in the hospital, the duration of mechanical ventilation, and the outcome in critically ill adults who are hospitalized for long periods is not known. METHODS: We carried out two prospective, multicenter, double-blind, randomized, placebo-controlled trials in parallel involving 247 Finnish patients and 285 patients in other European countries who had been in an intensive care unit for 5 to 7 days and who were expected to require intensive care for at least 10 days. The patients had had cardiac surgery, abdominal surgery, multiple trauma, or acute respiratory failure. The patients received either growth hormone (mean [+/-SD] daily dose, 0.10 +/- 0.02 mg per kilogram of body weight) or placebo until discharge from intensive care or for a maximum of 21 days. RESULTS: The in-hospital mortality rate was higher in the patients who received growth hormone than in those who did not (P<0.001 for both studies). In the Finnish study, the mortality rate was 39 percent in the growth hormone group, as compared with 20 percent in the placebo group. The respective rates in the multinational study were 44 percent and 18 percent. The relative risk of death for patients receiving growth hormone was 1.9 (95 percent confidence interval, 1.3 to 2.9) in the Finnish study and 2.4 (95 percent confidence interval, 1.6 to 3.5) in the multinational study. Among the survivors, the length of stay in intensive care and in the hospital and the duration of mechanical ventilation were prolonged in the growth hormone group. CONCLUSIONS: In patients with prolonged critical illness, high doses of growth hormone are associated with increased morbidity and mortality.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A large multicenter study by Takala et al (264) showed that the administration of high doses of GH (0.1 mg/kg/d) in critically ill patients (TBI patients were not included), instead of improving outcome, actually doubled mortality.”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [264]
Citations
Cites
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
Effects of Recombinant Human Growth Hormone on Donor-site Healing in Severely Burned Children
HERNDON, D. N., BARROW, R. E., KUNKEL, K. R., BROEMELING, L., & RUTAN, R. L. (1990) · Annals of Surgery · doi:10.1097/00000658-199010000-00005 · Cited by 400
Ross, R., Miell, J., Freeman, E., Jones, J., Matthews, D., Preece, M., & Buchanan, C. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb03495.x · Cited by 286
MUSCLE PROTEIN TURNOVER AND THE WASTING DUE TO INJURY AND DISEASE
Rennie, M. J. (1985) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a072060 · Cited by 260
JIANG, Z.-M., HE, G.-Z., ZHANG, S.-Y., WANG, X.-R., YANG, N.-F., ZHU, Y. U., & WILMORE, D. W. (1989) · Annals of Surgery · doi:10.1097/00000658-198910000-00012 · Cited by 243
Fatigue and cardiorespiratory function following abdominal surgery
Christensen, T., Bendix, T., & Kehlet, H. (1982) · Journal of British Surgery · doi:10.1002/bjs.1800690721 · Cited by 226
Gore, D. C. (1991) · Archives of Surgery · doi:10.1001/archsurg.1991.01410250042006 · Cited by 212
Pape, G. S., Friedman, M., Underwood, L. E., & Clemmons, D. R. (1991) · Chest · doi:10.1378/chest.99.6.1495 · Cited by 190
POSTOPERATIVE POSITIVE NITROGEN BALANCE WITH INTRAVENOUS HYPONUTRITION AND GROWTH HORMONE
Ponting, G. A., Teale, T. D., Halliday, D., & Sim, A. J. W. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91232-9 · Cited by 176
Timmins, A. C. F., Cotterill, A. M., Cwyfan Hughes, S. C., Holly, J. M. P., Ross, R. J. M., Blum, W., & Hinds, C. J. (1996) · Critical Care Medicine · doi:10.1097/00003246-199609000-00006 · Cited by 163
Self-citation
Research works printed but not linked: 5
- 10.1210/jc.74.4.865 · doi:10.1210/jc.74.4.865
- Gatzen C, 1992, Surgery, 112, 181
- Jeevanandam M, 1994, Am J Physiol, 267, E560
- 10.1002/bjs.1800830214 · doi:10.1002/bjs.1800830214
- Tacke J, 1994, Infusionsther Transfusionsmed, 21, 24
Cited by
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Krinsley, J. S. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.12.1471 · Cited by 1,165
Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives
Rolland, Y., Czerwinski, S., van Kan, G. A., Morley, J. E., Cesari, M., Onder, G., Woo, J., Baumgartner, R., Pillard, F., Boirie, Y., et al. (2008) · The Journal of nutrition, health and aging · doi:10.1007/bf02982704 · Cited by 1,071
Effects of Growth Hormone on Glucose, Lipid, and Protein Metabolism in Human Subjects
Møller, N., & Jørgensen, J. O. L. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0027 · Cited by 1,039
Glucose Control and Mortality in Critically Ill Patients
Finney, S. J. (2003) · JAMA · doi:10.1001/jama.290.15.2041 · Cited by 1,055
Metadata
- Authors
- Takala, J., Ruokonen, E., Webster, N. R., Nielsen, M. S., Zandstra, D. F., Vundelinckx, G., & Hinds, C. J.
- Affiliations
- Kuopio University Hospital (FI)
- Aberdeen Royal Infirmary (GB)
- Southampton General Hospital (GB)
- OLVG (NL)
- St Bartholomew's Hospital (GB)
- ORCID
- Hinds, Charles J.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1999-09-09
- Volume
- 341
- Issue
- 11
- Pages
- 785-792
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2325918023
- Semantic Scholar
- df3f1b6ae4a32c0e6ba80c072286829660b15349
- Cited by
- 1,023
- References
- 37
- Citations by year
- 2026: 18 · 2025: 10 · 2024: 11 · 2023: 13 · 2022: 11 · 2021: 24 · 2020: 24 · 2019: 22 · 2018: 21 · 2017: 29 · 2016: 26 · 2015: 44 · 2014: 25 · 2013: 40 · 2012: 44
- FWCI
- 37.71
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Nursing › Nutrition and Dietetics › Clinical Nutrition and Gastroenterology
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Keywords
- growth hormone, critically ill adults, in-hospital mortality, ICU length of stay, mechanical ventilation duration, cardiac surgery, abdominal surgery, polytrauma, acute respiratory failure, adverse effects of growth hormone
- MeSH terms
- Adolescent, Adult, Aged, Energy Intake, Cause of Death, Critical Care, Double-Blind Method, Female, Humans, Insulin-Like Growth Factor I, Male, Middle Aged, Multiple Organ Failure, Prospective Studies, Risk, Shock, Septic, Critical Illness, Hospital Mortality, Human Growth Hormone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Increased Mortality Associated with Growth Hormone Treatment in Critically Ill Adults. https://app.cochat.ai/papers/10.1056/nejm199909093411102
- The paper
- Takala, J., Ruokonen, E., Webster, N. R., Nielsen, M. S., Zandstra, D. F., Vundelinckx, G., & Hinds, C. J. (1999). Increased Mortality Associated with Growth Hormone Treatment in Critically Ill Adults. New England Journal of Medicine. https://doi.org/10.1056/nejm199909093411102
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.